2,963
Views
15
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

An association between transient hypokalemia and severe acute oxaliplatin-related toxicity predominantly in women

, , &
Pages 515-517 | Received 09 Oct 2009, Accepted 03 Nov 2009, Published online: 21 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francesca Aroldi, Tiziana Prochilo, Paola Bertocchi & Alberto Zaniboni. (2015) Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management. Journal of Chemotherapy 27:2, pages 63-66.
Read now

Articles from other publishers (14)

Mustafa Ileriturk, Duygu Ileriturk, Ozge Kandemir, Nurhan Akaras, Hasan Simsek, Ender Erdogan & Fatih M. Kandemir. (2023) Naringin attenuates oxaliplatin‐induced nephrotoxicity and hepatotoxicity: A molecular, biochemical, and histopathological approach in a rat model. Journal of Biochemical and Molecular Toxicology.
Crossref
Ranjit Singh, Anjleena Malhotra & Ranju Bansal. 2023. Medicinal Chemistry of Chemotherapeutic Agents. Medicinal Chemistry of Chemotherapeutic Agents 499 537 .
María M. Capotondo, Gustavo Aroca-Martinez, Sergio R. Specterman & Carlos G. Musso. 2023.
Stefka Ivanova. (2022) Comparative assessment of clinical trials, indications, pharmacokinetic parameters and side effects of approved platinum drugs. Pharmacia 69:1, pages 1-7.
Crossref
Blandine Aloy, Nicolas Janus, Corine Isnard-Bagnis, Gilbert Deray & Vincent Launay-Vacher. (2021) Toxicité rénale des anticancéreux. Néphrologie & Thérapeutique 17:7, pages 553-563.
Crossref
Shruti Gupta, Ignacio Portales-Castillo, Amir Daher & Abhijat Kitchlu. (2021) Conventional Chemotherapy Nephrotoxicity. Advances in Chronic Kidney Disease 28:5, pages 402-414.e1.
Crossref
Raghvendra Pandey, Prashant Kumar Singh & Alok Kumar Shrivastava. 2021. Colon Cancer Diagnosis and Therapy. Colon Cancer Diagnosis and Therapy 269 301 .
BEN SPRANGERS, LAURA COSMAI & CAMILLO PORTA. 2020. Onco-Nephrology. Onco-Nephrology 127 153.e11 .
Tao Sun, Guangping Zhang, Qingbing Wang, Zhongyuan Guo, Qinjun Chen, Xinli Chen, Yifei Lu, Yu Zhang, Yujie Zhang, Qin Guo, Xiang Gao, Yongzhong Cheng & Chen Jiang. (2019) Pre-blocked molecular shuttle as an in-situ real-time theranostics. Biomaterials 204, pages 46-58.
Crossref
Nguyen Thi Thanh Chi & Truong Thi Cam Mai. (2018) In vitro cytotoxicity of a series of cis -platinum(II) complexes bearing piperidine . Vietnam Journal of Chemistry 56:2, pages 244-248.
Crossref
Josef Mayr, Petra Heffeter, Diana Groza, Luis Galvez, Gunda Koellensperger, Alexander Roller, Beatrix Alte, Melanie Haider, Walter Berger, Christian R. Kowol & Bernhard K. Keppler. (2017) An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo. Chemical Science 8:3, pages 2241-2250.
Crossref
Hong Li, Xiangqian Gao, Ran Liu, Yu Wang, Menghua Zhang, Zheng Fu, Yi Mi, Yiqiang Wang, Zhi Yao & Qingzhi Gao. (2015) Glucose conjugated platinum(II) complex: Antitumor superiority to oxaliplatin, combination effect and mechanism of action. European Journal of Medicinal Chemistry 101, pages 400-408.
Crossref
Kubilay Karabacak, Murat Kadan, Erkan Kaya, Baris Durgun, Gokhan Arslan, Suat Doganci, Cengiz Bolcal & Ufuk Demirkilic. (2015) Oxaliplatin Induced Digital Ischemia and Necrosis. Case Reports in Vascular Medicine 2015, pages 1-3.
Crossref
. (2010) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 19:11, pages i-xii.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.